IRIS
RIVARA, Mirko
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.953
AS - Asia 2.313
EU - Europa 2.009
SA - Sud America 271
AF - Africa 136
Continente sconosciuto - Info sul continente non disponibili 79
OC - Oceania 1
Totale 7.762
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.830
SG - Singapore 759
CN - Cina 707
IT - Italia 497
VN - Vietnam 348
FI - Finlandia 297
SE - Svezia 251
IE - Irlanda 232
BR - Brasile 198
DE - Germania 197
HK - Hong Kong 187
UA - Ucraina 142
NL - Olanda 88
GB - Regno Unito 84
BD - Bangladesh 81
ZA - Sudafrica 73
FR - Francia 71
CA - Canada 66
RU - Federazione Russa 62
TR - Turchia 42
IN - India 38
CI - Costa d'Avorio 25
KR - Corea 22
MX - Messico 20
PH - Filippine 20
JP - Giappone 19
AR - Argentina 18
EC - Ecuador 17
CZ - Repubblica Ceca 16
IQ - Iraq 16
BE - Belgio 15
CO - Colombia 14
PL - Polonia 12
TH - Thailandia 12
ID - Indonesia 11
CR - Costa Rica 10
PK - Pakistan 10
ES - Italia 9
VE - Venezuela 9
EG - Egitto 8
CL - Cile 7
LT - Lituania 7
MA - Marocco 7
PT - Portogallo 7
TN - Tunisia 7
AT - Austria 6
JO - Giordania 6
GT - Guatemala 5
PR - Porto Rico 5
HN - Honduras 4
TW - Taiwan 4
AL - Albania 3
AZ - Azerbaigian 3
BB - Barbados 3
BO - Bolivia 3
ET - Etiopia 3
IR - Iran 3
KE - Kenya 3
NI - Nicaragua 3
NP - Nepal 3
PY - Paraguay 3
QA - Qatar 3
SA - Arabia Saudita 3
AM - Armenia 2
EE - Estonia 2
JM - Giamaica 2
KW - Kuwait 2
LY - Libia 2
PE - Perù 2
PS - Palestinian Territory 2
SN - Senegal 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AU - Australia 1
BF - Burkina Faso 1
BH - Bahrain 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CH - Svizzera 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DZ - Algeria 1
EU - Europa 1
GE - Georgia 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
KN - Saint Kitts e Nevis 1
LI - Liechtenstein 1
LV - Lettonia 1
MD - Moldavia 1
MU - Mauritius 1
MY - Malesia 1
OM - Oman 1
PA - Panama 1
RO - Romania 1
RS - Serbia 1
SC - Seychelles 1
Totale 7.680
Salva come PNG Salva come JPEG
Città #
Singapore 397
Ashburn 361
San Jose 294
Dublin 232
Chandler 226
Santa Clara 188
Beijing 177
Hong Kong 176
Jacksonville 154
Dallas 116
Parma 100
Ann Arbor 97
Council Bluffs 97
Ho Chi Minh City 97
Boardman 93
Hanoi 87
Johannesburg 71
Munich 71
New York 71
Hefei 69
Dearborn 67
Nanjing 62
Los Angeles 60
Milan 55
Shanghai 51
Lauterbourg 45
Princeton 45
Washington 42
Chicago 35
Helsinki 34
Wilmington 32
Izmir 31
San Mateo 29
Toronto 29
Buffalo 26
Moscow 26
Abidjan 25
Frankfurt am Main 25
Phoenix 24
Turku 24
London 22
Seoul 19
Shenyang 18
Guangzhou 17
Nanchang 17
Rome 17
Seattle 17
São Paulo 17
Tokyo 17
Columbus 16
Da Nang 16
Haiphong 16
Jinan 16
Kunming 16
Modena 15
Bremen 14
Brussels 14
Des Moines 14
Hebei 14
The Dalles 13
Bologna 12
Jiaxing 11
Brno 10
Brooklyn 10
Chennai 10
Montreal 10
Reggio Emilia 10
Woodbridge 10
Warsaw 9
Amsterdam 8
Changsha 8
Nuremberg 8
Tianjin 8
Atlanta 7
Baghdad 7
Bengaluru 7
Guayaquil 7
Ottawa 7
Quito 7
San José 7
Ankara 6
Belo Horizonte 6
Chengdu 6
Genoa 6
Houston 6
Jakarta 6
Manchester 6
Mexico City 6
North Bergen 6
Piacenza 6
Stockholm 6
Vienna 6
Amman 5
Auburn Hills 5
Falls Church 5
Hangzhou 5
Norwalk 5
Redondo Beach 5
Rio de Janeiro 5
Thái Bình 5
Totale 4.551
Salva come PNG Salva come JPEG
Nome #
Chemico-Physical Properties of Some 1,1′-Bis-alkyl-2,2′-hexane-1,6-diyl-bispyridinium Chlorides Hydrogenated and Partially Fluorinated for Gene Delivery 237
NEW ALKBH2 AND ALKBH5 INHIBITORS FOR TREATING GLIOBLASTOMA 233
5-Benzylidene-hydantoins: synthesis and antiproliferative activity on A549 lung cancer cell line 223
Gene-Delivery Ability of New Hydrogenated and Partially Fluorinated Gemini bispyridinium Surfactants with Six Methylene Spacers 218
3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell line 213
Synthesis, biological activity, QSAR and QSPR study of 2/aminobenzimidazole derivatives as potent H3-antagonists 207
The Role of HB-Donor Groups in the Heterocyclic Polar Fragment of H3-Antagonists. I. Synthesis and Biological Assays 194
Validation of a histamine H3 receptor model through structure–activity relationships for classical H3 antagonists 190
Cognition enhancing effect in rats of a selected histamine H3 receptor antagonist with good brain penetration 186
MV1035 Overcomes Temozolomide Resistance in Patient-Derived Glioblastoma Stem Cell Lines 175
Dibasic non-imidazole histamine H3 receptor antagonists with a rigid byphenyl scaffold. 172
New ALKBH2 and ALKBH5 inhibitors for treating glioblastoma 170
A Short and Efficient Synthesis of the Selective H4 Receptor Agonist 4-Methylhistamine 170
QSAR study of 2-aminobenzimidazole derivatives as H3 antagonists 165
Chiral NMR discrimination of the diastereoisomeric salts of the H(3)-antagonist 2-[3-(1H-imidazol-4-ylmethyl)piperidin-1-yl]-1H-benzimidazole. 164
COMPOSITIONS AND METHODS FOR BLOCKING SODIUM CHANNELS 164
Development and validation of a LC-MS method with electrospray ionization for the determination of the imidazole H(3) antagonist ROS203 in rat plasma. 164
2,4(5)-Diarylimidazoles: Synthesis and Biological Evaluation of a New Class of Sodium Channel Blockers against hNav1.2 161
2,4(5)-Diarylimidazoles as Inhibitors of hNaV1.2 Sodium Channels: Pharmacological Evaluationand Structure-Property Relationships 160
Antioxidant and cytoprotective activity of indole derivatives related to melatonin 160
Advances in Design and Development of Sodium Channel Blockers. 157
COMPOSITIONS AND METHODS FOR BLOCKING SODIUM CHANNELS 157
Synthesis and biological evaluation of new non-imidazole H(3)-receptor antagonists of the 2-aminobenzimidazole series 156
Anticonvulsant Activity of 2,4(1H)-Diarylimidazoles in Mice and Rats Acute Seizure Models 150
In vitro and in vivo pharmacological analysis of imidazole-free histamine H3 receptor antagonists: promising results for a brain-penetrating H3 blocker with weak anticholinesterase activity. 149
Anticonvulsant Activity of 2,4(5)-Diarylimidazoles in Mice and Rat Models 149
Development of a GPCR model for SAR interpretation of classical and new H3 antagonists 149
COMPOSITIONS AND METHODS FOR BLOCKING SODIUM CHANNELS 149
Biological evaluation of imidazobenzoxazines, imidazobenzoxazin-5-ones and imidazobenzoxazin-5-thiones as sodium channel blockers 147
Novel Sodium Channel Antagonists in the Treatment of Neuropathic Pain 143
Discovery of antitubercular 2,4-diphenyl-1H-imidazoles from chemical library repositioning and rational design 141
Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity. 136
Drug repurposing approaches to fight Dengue virus infection and related diseases 134
Synthesis, antioxidant activity and structure-activity relationships for a new series of 2-(N-acylaminoethyl)indoles with melatonin-like cytoprotective activity 129
A Practical Synthesis of 2,4(5)-Diarylimidazoles from Simple Building Blocks 127
Potential in-vitro antiviral activity of MV1035 on SARS-CoV-2 wild type viruses 126
In vivo Screening of Diarylimidazoles as Anticonvulsant Agents 124
Inhibition of NaV1.6 sodium channel currents by a novel series of 1,4-disubstituted-triazole derivatives obtained via copper-catalyzed click chemistry 124
IMIDAZOBENZOXAZIN-5-THIONE (MV1035) TO OVERCOME THE BLOOD-BRAIN BARRIER AND TARGET CNS DISEASES 123
NMR Analysis of a Series of Imidazobenzoxazines 119
Sodium channel blockers for neuropathic pain. 118
Recent Advances in the Medicinal Chemistry of Sodium Channel Blockers and their Therapeutic Potential 116
Sodium Channel Blocking Activity and In-vivo Testing of New Phenyl-imidazole Derivatives. 116
Microwave Assisted Efficient Synthesis of Imidazole-based Privileged Structure 115
Imidazole H3-antagonists: Relationship between Structure and Ex-vivo binding to Rat Brain H3-Receptors 115
Sodium channel blockers: a patent review (2010 - 2014) 110
Sodium Channel Blockers as Therapeutic Target for Treating Epilepsy: Recent Updates 109
Synthesis and stability in biological media of 1H-imidazole-1-carboxylates of ROS203, an antagonist of the histamine H3 receptor. 105
NaV1.1 and NaV1.6 selective compounds reduce the behavior phenotype and epileptiform activity in a novel zebrafish model for Dravet syndrome 98
Recent advances in the discovery of ALKBH 1–8 inhibitors. 85
Subtype-selective small molecule inhibitors reveal a fundamental role for Nav1.7 in nociceptor electrogenesis, axonal conduction and presynaptic release 79
From Sodium Channels Blockers to Dual ALKBH2/ALKBH5 Inhibitors: a Novel Therapeutic Strategy for Glioblastoma Treatment. 29
3D Bioprinted Glioblastoma Multiforme Models: How the Extracellular Matrix Glycosignature Influences Drug Response 28
Design and Biological Evaluation of ALKBH2 and ALKBH5 Inhibitors as Adjuvants to Temozolomide-based Glioblastoma Treatment. 24
Totale 7.762
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.961
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.961
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022219 0 0 0 18 14 7 29 26 21 17 17 70
2022/2023929 106 108 68 57 71 118 17 44 275 12 36 17
2023/2024411 22 32 11 14 43 84 38 29 19 21 35 63
2024/20251.277 64 78 99 90 72 137 41 77 101 114 128 276
2025/20262.907 251 291 359 305 396 171 305 90 328 216 104 91
2026/2027652 83 155 177 237 0 0 0 0 0 0 0 0
Totale 7.762